Bristol-Myers Squibb (BMY) Said to Make Takeover Approach to Aurinia Pharmaceuticals (AUPH) - Bloomberg

October 22, 2021 3:48 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

(Updated - October 22, 2021 3:50 PM EDT)

Bristol-Myers Squibb (NYSE: BMY) has expressed interest in acquiring Aurinia Pharmaceuticals (NASDAQ: AUPH), according to Bloomberg, citing people familiar with the matter.

Bristol-Myers recently approached Aurinia about a deal, the report said.

No final decisions have been made.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors